Involvement of P-glycoprotein in blood-brain barrier transport of pentazocine in rats using brain uptake index method

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 6, 2004, Pages 932-935

  Moriki, Yoshiaki ^a   Suzuki, Toyofumi ^a   Fukami, Toshiro ^a   Hanano, Manabu ^a   Tomono, Kazuo ^a   Watanabe, Jun ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Brain uptake index; Efflux transport; P glycoprotein; Pentazocine

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; PENTAZOCINE; QUINIDINE; VERAPAMIL; VINBLASTINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TRANSPORT; FEMALE; IN VIVO STUDY; INJECTION; MEMBRANE TRANSPORT; NONHUMAN; RADIOACTIVITY; RAT; ANIMAL; COMPARATIVE STUDY; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; FEMALE; P-GLYCOPROTEIN; PENTAZOCINE; RATS; RATS, WISTAR;

EID: 12344321374     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.932     Document Type: Article

References (24)

1. Jasinski D. R., Martin W. R., Hoeldtke R. D., Clin. Pharmacol. Ther., 11, 385-403 (1970).
2. Suzuki T., Moriki Y., Goto H., Tomono K., Hanano M., Watanabe J., Biol. Pharm. Bull., 25, 1351-1355 (2002).
3. Suzuki T., Oshimi M., Tomono K., Hanano M., Watanabe J., J. Pharm. Sci., 91, 2346-2353 (2002).
4. Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R., Bertino J. R., Proc. Natl. Acad. Sci. U.S.A., 86, 695-698 (1989).
5. Jette L., Tetu B., Beliveau R., Biochim. Biophys. Acta, 1150, 147-154 (1993).
6. Tatsuta T., Naito M., Oh-hara T., Sugawara I., Tsuruo T., J. Biol. Chem., 267, 20383-20391 (1992).
7. Seelig A., Eur. J. Biochem., 251, 252-261 (1998).
8. Seelig A., Blatter X. L., Wohnsland F., Int. J. Clin. Pharmacol. Ther., 38, 111-121 (2000).
9. Callaghan R., Riordan J. R., J. Biol. Chem., 268, 16059-16064 (1993).
10. Hofsli E., Nissen-Meyer J., Cancer Res., 50, 3997-4002 (1990).
11. Kakee A., Terasaki T., Sugiyama Y., J. Pharmacol. Exp. Ther., 277, 1550-1559 (1996).
12. Terasaki T., Hosoya K., Adv. Drug Deliv. Rev., 36, 195-209 (1999).
13. Ohtsuki S., Asaba H., Takanaga H., Deguchi T., Hosoya K., Otagiri M., Terasaki T., J. Neurochem., 83, 57-66 (2002).
14. Mori S., Takanaga H., Ohtsuki S., Deguchi T., Kang Y. S., Hosoya K., Terasaki T., J. Cereb. Blood Flow Metab., 23, 432-440 (2003).
15. Pardridge W. M., Sakiyama R., Fierer G., J. Clin. Invest., 71, 900-908 (1983).
16. Oldendolf W. H., Brain Res., 24, 372-376 (1970).
17. Pardridge W. M., Sakiyama R., Fierer G., Am. J. Physiol., 247, R582-R588 (1984).
18. Pardridge W. M., Fierer G., J. Cereb. Blood Flow Metab., 5, 275-281 (1985).
19. Hardebo J. E., Nilsson B., Acta Physiol. Scand., 107, 153-159 (1979).
20. Tamai I., Kido Y., Yamashita J., Sai Y., Tsuji A., J. Drug Target., 8, 383-393 (2000).
21. Murata M., Tamai I., Kato H., Nagata O., Kato H., Tsuji A., J. Pharmacol. Exp. Ther., 290, 51-57 (1999).
22. Kawamura K., Kobayashi T., Matsuno K., Ishiwata K., Synapse, 48, 80-86 (2003).
23. Dagenais C., Graff C. L., Pollack G. M., Biochem. Pharmacol., 67, 269-276 (2004).
24. Wandel C., Kim R., Wood M., Wood A., Anesthesiology, 96, 913-920 (2002).